ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MAK CAPITAL ONE LLC | 5,191,600 | $8,255,000 | 4.47% |
RTW INVESTMENTS, LP | 13,749,383 | $21,862,000 | 2.04% |
ARMISTICE CAPITAL, LLC | 4,300,000 | $6,837,000 | 0.52% |
DAFNA Capital Management LLC | 630,182 | $1,002,000 | 0.50% |
Rock Springs Capital Management LP | 2,325,000 | $3,697,000 | 0.18% |
683 Capital Management, LLC | 1,000,000 | $1,590,000 | 0.10% |
Alambic Investment Management, L.P. | 133,698 | $213,000 | 0.09% |
South Dakota Investment Council | 3,037,004 | $7,310,000 | 0.08% |
Alpine Global Management, LLC | 205,172 | $326,000 | 0.08% |
Rhenman & Partners Asset Management AB | 402,800 | $640,000 | 0.07% |